HEADER HYDROLASE, REPLICATION 31-JUL-06 2HW0 TITLE NMR SOLUTION STRUCTURE OF THE NUCLEASE DOMAIN FROM THE REPLICATOR TITLE 2 INITIATOR PROTEIN FROM PORCINE CIRCOVIRUS PCV2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPLICASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 2-116 OF REP PCV2; COMPND 5 EC: 3.1.21.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PORCINE CIRCOVIRUS 2; SOURCE 3 ORGANISM_TAXID: 85708; SOURCE 4 GENE: REP, ORF1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: ROSSETA (DE3) PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET3A KEYWDS ALPHA+BETA, HYDROLASE, REPLICATION EXPDTA SOLUTION NMR NUMMDL 31 MDLTYP MINIMIZED AVERAGE AUTHOR S.VEGA-ROCHA,I.L.BYEON,B.GRONENBORN,A.M.GRONENBORN,R.CAMPOS-OLIVAS REVDAT 3 09-MAR-22 2HW0 1 REMARK REVDAT 2 24-FEB-09 2HW0 1 VERSN REVDAT 1 12-JUN-07 2HW0 0 JRNL AUTH S.VEGA-ROCHA,I.L.BYEON,B.GRONENBORN,A.M.GRONENBORN, JRNL AUTH 2 R.CAMPOS-OLIVAS JRNL TITL SOLUTION STRUCTURE, DIVALENT METAL AND DNA BINDING OF THE JRNL TITL 2 ENDONUCLEASE DOMAIN FROM THE REPLICATION INITIATION PROTEIN JRNL TITL 3 FROM PORCINE CIRCOVIRUS 2 JRNL REF J.MOL.BIOL. V. 367 473 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17275023 JRNL DOI 10.1016/J.JMB.2007.01.002 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CYANA 2.0 REMARK 3 AUTHORS : BRUKER (XWINNMR), PETER GUENTERT (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HW0 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000038827. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.6 REMARK 210 IONIC STRENGTH : 0.264 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.8MM REP2-116_PCV2 U-10% 13C;U REMARK 210 -15N, 20 MM SODIUM PHOSPHATE, REMARK 210 100MM NACL, 1MM DTT, 8% D2O; REMARK 210 0.8MM REP2-116_PCV2 U-10% 13C;U- REMARK 210 15N, 20 MM SODIUM PHOSPHATE, REMARK 210 100MM NACL, 1MM DTT, 100% D2O; REMARK 210 0.8MM REP2-116_PCV2 U-13C; U-15N, REMARK 210 20 MM SODIUM PHOSPHATE, 100MM REMARK 210 NACL, 1MM DTT, 8% D2O; 0.8MM REMARK 210 REP2-116_PCV2 U-13C;U-15N, 20 MM REMARK 210 SODIUM PHOSPHATE, 100MM NACL, REMARK 210 1MM DTT, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; HNHA; REMARK 210 HNHB; 4D_13C/15N-SEPARATED_NOESY; REMARK 210 2D HNCOCG AROMATIC; 2D HNCG REMARK 210 AROMATIC; 4D_13C-SEPARATED_NOESY; REMARK 210 2D 1H-15N HSQC; 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW 5.0.4, CYANA 2.0, REMARK 210 NMRPIPE X, TALOS X REMARK 210 METHOD USED : 30 CONFORMERS CALCULATED USING REMARK 210 SIMULATED ANHEALING IN TORSION REMARK 210 ANGLE SPACE WITH CYANA2.0 REMARK 210 (MODELS 2-31) & AVERAGE REMARK 210 STRUCTURE AFTER CYANA VARIABLE REMARK 210 TARGET FUNCTION MINIMISATION REMARK 210 (MODEL 1) REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 31 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 110 80.55 -69.80 REMARK 500 1 GLN A 115 -55.98 -168.48 REMARK 500 2 LYS A 4 -172.33 56.08 REMARK 500 2 PRO A 110 82.40 -69.73 REMARK 500 3 ASN A 50 -169.96 -60.77 REMARK 500 3 GLU A 51 172.85 -53.95 REMARK 500 3 PRO A 110 81.94 -69.76 REMARK 500 3 GLN A 115 -64.44 -92.63 REMARK 500 4 ARG A 8 81.21 -161.64 REMARK 500 4 GLN A 115 141.61 -171.95 REMARK 500 5 SER A 3 118.27 -167.67 REMARK 500 5 ASN A 50 -169.84 -61.00 REMARK 500 5 GLU A 51 170.52 -54.68 REMARK 500 5 PRO A 110 74.81 -69.76 REMARK 500 5 SER A 112 -64.14 -121.40 REMARK 500 5 GLN A 115 -61.30 -154.23 REMARK 500 6 GLU A 51 101.65 -179.36 REMARK 500 6 PRO A 110 80.58 -69.72 REMARK 500 7 ASN A 6 -73.97 -170.61 REMARK 500 7 ARG A 8 -63.46 -170.01 REMARK 500 7 SER A 9 -174.61 61.74 REMARK 500 7 PRO A 110 76.65 -69.77 REMARK 500 7 SER A 112 -169.97 -110.48 REMARK 500 8 SER A 3 114.30 -175.99 REMARK 500 8 ASN A 50 -169.61 -60.36 REMARK 500 8 PRO A 110 78.46 -69.75 REMARK 500 8 SER A 112 47.70 -175.39 REMARK 500 9 LYS A 4 115.32 -178.18 REMARK 500 9 ASN A 50 -170.12 -60.97 REMARK 500 9 GLU A 51 -177.60 -60.12 REMARK 500 10 SER A 9 -47.28 -163.50 REMARK 500 10 ASN A 50 -170.31 -61.00 REMARK 500 10 GLU A 51 175.96 -59.36 REMARK 500 11 ASN A 50 38.60 -97.67 REMARK 500 11 GLN A 115 69.75 -109.05 REMARK 500 12 ASN A 50 -170.05 -61.13 REMARK 500 12 GLU A 51 175.87 -56.84 REMARK 500 13 PRO A 110 83.54 -69.70 REMARK 500 14 ASN A 6 98.39 -179.31 REMARK 500 14 ASN A 50 38.98 -97.93 REMARK 500 14 GLN A 113 -58.23 -142.60 REMARK 500 15 SER A 3 -176.19 63.07 REMARK 500 15 LYS A 4 177.65 63.27 REMARK 500 15 SER A 9 -74.51 -123.56 REMARK 500 16 SER A 3 84.29 -158.28 REMARK 500 16 ARG A 8 -174.63 -174.56 REMARK 500 16 PRO A 110 79.62 -69.69 REMARK 500 17 SER A 3 -179.56 -58.69 REMARK 500 17 ASN A 6 134.29 -175.47 REMARK 500 17 SER A 9 164.57 63.20 REMARK 500 REMARK 500 THIS ENTRY HAS 99 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6928 RELATED DB: BMRB REMARK 900 ASSIGNMENT OF RESONANCES REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS STATE THAT THE POLYPEPTIDE PURIFIED FROM E.COLI REMARK 999 STARTS WITH AMINO ACID NUMBER 2 OF THE COMPLETE PROTEIN REMARK 999 BECAUSE THERE IS IN VIVO PROCESSING OF THE RESIDUE MET1. REMARK 999 THIS HAS BEEN VERIFIED BY MASS SPECTROMETRY OF THE REMARK 999 DIFFERENTLY LABELED SAMPLES PRODUCED. DBREF 2HW0 A 2 116 UNP Q77NR8 Q77NR8_PCV2 2 116 SEQRES 1 A 115 PRO SER LYS LYS ASN GLY ARG SER GLY PRO GLN PRO HIS SEQRES 2 A 115 LYS ARG TRP VAL PHE THR LEU ASN ASN PRO SER GLU ASP SEQRES 3 A 115 GLU ARG LYS LYS ILE ARG ASP LEU PRO ILE SER LEU PHE SEQRES 4 A 115 ASP TYR PHE ILE VAL GLY GLU GLU GLY ASN GLU GLU GLY SEQRES 5 A 115 ARG THR PRO HIS LEU GLN GLY PHE ALA ASN PHE VAL LYS SEQRES 6 A 115 LYS GLN THR PHE ASN LYS VAL LYS TRP TYR LEU GLY ALA SEQRES 7 A 115 ARG CYS HIS ILE GLU LYS ALA LYS GLY THR ASP GLN GLN SEQRES 8 A 115 ASN LYS GLU TYR CYS SER LYS GLU GLY ASN LEU LEU MET SEQRES 9 A 115 GLU CYS GLY ALA PRO ARG SER GLN GLY GLN ARG HELIX 1 1 SER A 25 ASP A 34 1 10 HELIX 2 2 PRO A 36 SER A 38 5 3 HELIX 3 3 THR A 69 GLY A 78 1 10 HELIX 4 4 THR A 89 LYS A 99 1 11 SHEET 1 A 5 HIS A 82 GLU A 84 0 SHEET 2 A 5 TRP A 17 ASN A 22 -1 N VAL A 18 O GLU A 84 SHEET 3 A 5 HIS A 57 PHE A 64 -1 O LEU A 58 N LEU A 21 SHEET 4 A 5 PHE A 40 GLU A 48 -1 N TYR A 42 O ASN A 63 SHEET 5 A 5 LEU A 103 GLY A 108 -1 O CYS A 107 N PHE A 43 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1